logo-loader
viewCollagen Solutions PLC

Collagen Solutions reports strong growth in its tissue business in first half

Collagen Solutions PLC's (LON:COS) Jamal Rushdy and Hilary Spence update Proactive London's Andrew Scott on first half performance - their third consecutive six-month period of double-digit sales growth.

Revenues increased by 14% to £2.23mln in the period ended September 30. Tissue sales more than doubled.

Quick facts: Collagen Solutions PLC

Price: 3.4 GBX

LSE:COS
Market: LSE
Market Cap: £15.09 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Collagen Solutions PLC named herein, including the promotion by the Company of Collagen Solutions PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Collagen Solutions released financial number showing more...

Collagen Solutions (LON: COS) CEO Jamal Rushdy joined Steve Darling from Proactive to discuss the company releasing their financial numbers that show impressive double-digit sales growth.  Rushdy talks about the numbers and also their tissue division that continues to be a revenue driver.

on 23/10/19

RNS

Half-year Report

1 week, 5 days ago

Investor results presentation

3 weeks, 5 days ago

Directorate Change

on 13/11/19

Result of AGM

on 28/8/19

AGM Statement

on 28/8/19

2 min read